Paper20548947
The transcription factor REST is lost in aggressive breast cancer.
Wagoner MP and 5 others. PLoS Genet, 2010. Cited by 84 papers, by iCite.
Cite this record
ConductScience Library. The transcription factor REST is lost in aggressive breast cancer. Papers, record 20548947. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20548947
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alternative Splicing | Major topic |
| Breast Neoplasms | Major topic |
| Gene Expression Regulation, Neoplastic | Major topic |
| Repressor Proteins | Major topic |
| Cell Line | |
| Gene Expression Profiling | |
| Humans | |
| Prognosis | |
| RNA, Messenger | |
| Treatment Outcome | |
| RE1-Silencing Transcription Factor |
Source PubMed
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10334533 | Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. | J Clin Oncol | 1999 | https://conductscience.org/library/papers/10334533 | PubMed |
| 2 | 7697725 | REST: a mammalian silencer protein that restricts sodium channel gene expression to neurons. | Cell | 1995 | https://conductscience.org/library/papers/7697725 | PubMed |
| 3 | 14561745 | Distinct RE-1 silencing transcription factor-containing complexes interact with different target genes. | J Biol Chem | 2004 | https://conductscience.org/library/papers/14561745 | PubMed |
| 4 | 9037026 | A single zinc finger motif in the silencing factor REST represses the neural-specific type II sodium channel promoter. | Proc Natl Acad Sci U S A | 1997 | https://conductscience.org/library/papers/9037026 | PubMed |
| 5 | 16636895 | Syndecan-1 and syndecan-4 are overexpressed in an estrogen receptor-negative, highly proliferative breast carcinoma subtype. | Breast Cancer Res Treat | 2006 | https://conductscience.org/library/papers/16636895 | PubMed |
| 6 | 9873054 | Brain-derived neurotrophic factor expression in vivo is under the control of neuron-restrictive silencer element. | J Biol Chem | 1999 | https://conductscience.org/library/papers/9873054 | PubMed |
| 7 | 10430922 | Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. | Proc Natl Acad Sci U S A | 1999 | https://conductscience.org/library/papers/10430922 | PubMed |
| 8 | 19246391 | RE-1-silencing transcription factor shows tumor-suppressor functions and negatively regulates the oncogenic TAC1 in breast cancer cells. | Proc Natl Acad Sci U S A | 2009 | https://conductscience.org/library/papers/19246391 | PubMed |
| 9 | 18354483 | SCFbeta-TRCP controls oncogenic transformation and neural differentiation through REST degradation. | Nature | 2008 | https://conductscience.org/library/papers/18354483 | PubMed |
| 10 | 9454838 | Neuronal expression of zinc finger transcription factor REST/NRSF/XBR gene. | J Neurosci | 1998 | https://conductscience.org/library/papers/9454838 | PubMed |
| 11 | 18959480 | REST regulates distinct transcriptional networks in embryonic and neural stem cells. | PLoS Biol | 2008 | https://conductscience.org/library/papers/18959480 | PubMed |
| 12 | 15240883 | Genome-wide analysis of repressor element 1 silencing transcription factor/neuron-restrictive silencing factor (REST/NRSF) target genes. | Proc Natl Acad Sci U S A | 2004 | https://conductscience.org/library/papers/15240883 | PubMed |
| 13 | 17041593 | 2-Deoxy-D-glucose reduces epilepsy progression by NRSF-CtBP-dependent metabolic regulation of chromatin structure. | Nat Neurosci | 2006 | https://conductscience.org/library/papers/17041593 | PubMed |
| 14 | 15960972 | A genetic screen for candidate tumor suppressors identifies REST. | Cell | 2005 | https://conductscience.org/library/papers/15960972 | PubMed |
| 15 | 7871435 | The neuron-restrictive silencer factor (NRSF): a coordinate repressor of multiple neuron-specific genes. | Science | 1995 | https://conductscience.org/library/papers/7871435 | PubMed |
| 16 | 10766169 | A splice variant of the neuron-restrictive silencer factor repressor is expressed in small cell lung cancer: a potential role in derepression of neuroendocrine genes and a useful clinical marker. | Cancer Res | 2000 | https://conductscience.org/library/papers/10766169 | PubMed |
| 17 | 8790425 | Identification of potential target genes for the neuron-restrictive silencer factor. | Proc Natl Acad Sci U S A | 1996 | https://conductscience.org/library/papers/8790425 | PubMed |
| 18 | 17906450 | Gene expression profiling in breast cancer. | Curr Opin Oncol | 2007 | https://conductscience.org/library/papers/17906450 | PubMed |
| 19 | 18691967 | Mediator links epigenetic silencing of neuronal gene expression with x-linked mental retardation. | Mol Cell | 2008 | https://conductscience.org/library/papers/18691967 | PubMed |
| 20 | 15200951 | Localized domains of G9a-mediated histone methylation are required for silencing of neuronal genes. | Mol Cell | 2004 | https://conductscience.org/library/papers/15200951 | PubMed |
Cited by68
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 84 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42443498 | Transcription factor targeting strategies in cancer: mechanisms, challenges and cutting-edge progress. | Acta Pharmacol Sin | 2026 | https://conductscience.org/library/papers/42443498 | PubMed |
| 42146333 | BART-spatial unravels biologically significant transcriptional regulators from spatial omics data. | bioRxiv | 2026 | https://conductscience.org/library/papers/42146333 | PubMed |
| 41898612 | REST and RASSF1A Tumor Suppressor Genes in Peripheral Blood: Potential Molecular Markers in Breast Cancer. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41898612 | PubMed |
| 41465373 | Generation of a scFv Derived from an IgM-Producing Hybridoma for the Detection of REST Expression in Premalignant Lesions and Invasive Squamous Cell Carcinoma. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41465373 | PubMed |
| 40867559 | Membrane-Type 5 Matrix Metalloproteinase (MT5-MMP): Background and Proposed Roles in Normal Physiology and Disease. | Biomolecules | 2025 | https://conductscience.org/library/papers/40867559 | PubMed |
| 40464797 | Loss of negative regulation by HDAC1 and REST contributes to MAD1 overexpression in breast cancer. | Mol Biol Cell | 2025 | https://conductscience.org/library/papers/40464797 | PubMed |
| 39748436 | Unraveling the causal impact of smoking and its DNA methylation signatures on cardiovascular disease: Mendelian randomization and colocalization analysis. | Clin Epigenetics | 2025 | https://conductscience.org/library/papers/39748436 | PubMed |
| 39273639 | Functional Analysis of RE1 Silencing Transcription Factor as a Putative Tumor Suppressor in Human Endometrial Cancer. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39273639 | PubMed |
| 38777812 | Androgen deprivation induces neuroendocrine phenotypes in prostate cancer cells through CREB1/EZH2-mediated downregulation of REST. | Cell Death Discov | 2024 | https://conductscience.org/library/papers/38777812 | PubMed |
| 38184712 | DMT1-dependent endosome-mitochondria interactions regulate mitochondrial iron translocation and metastatic outgrowth. | Oncogene | 2024 | https://conductscience.org/library/papers/38184712 | PubMed |
| 37716001 | SRRM4-mediated REST to REST4 dysregulation promotes tumor growth and neural adaptation in breast cancer leading to brain metastasis. | Neuro Oncol | 2024 | https://conductscience.org/library/papers/37716001 | PubMed |
| 37648814 | Frequent ZNF217 mutations lead to transcriptional deregulation of interferon signal transduction via altered chromatin accessibility in B cell lymphoma. | Leukemia | 2023 | https://conductscience.org/library/papers/37648814 | PubMed |
| 37543278 | A novel GRK3-HDAC2 regulatory pathway is a key direct link between neuroendocrine differentiation and angiogenesis in prostate cancer progression. | Cancer Lett | 2023 | https://conductscience.org/library/papers/37543278 | PubMed |
| 37301955 | DNA methylation alterations at RE1-silencing transcription factor binding sites and their flanking regions in cancer. | Clin Epigenetics | 2023 | https://conductscience.org/library/papers/37301955 | PubMed |
| 36984538 | REST/NRSF Silencing Modifies Neuronal Gene Expression in siRNA-Treated HeLa Cells: A Preliminary Exploration in the Search for Neuronal Biomarkers of Cervical Cancer. | Medicina (Kaunas) | 2023 | https://conductscience.org/library/papers/36984538 | PubMed |
| 36650528 | An antisense amido-bridged nucleic acid gapmer oligonucleotide targeting SRRM4 alters REST splicing and exhibits anti-tumor effects in small cell lung cancer and prostate cancer cells. | Cancer Cell Int | 2023 | https://conductscience.org/library/papers/36650528 | PubMed |
| 36282915 | Loss of the repressor REST affects progesterone receptor function and promotes uterine leiomyoma pathogenesis. | Proc Natl Acad Sci U S A | 2022 | https://conductscience.org/library/papers/36282915 | PubMed |
| 35491677 | Significant decrease of a master regulator of genes (REST/NRSF) in high-grade squamous intraepithelial lesion and cervical cancer. | Biomed J | 2021 | https://conductscience.org/library/papers/35491677 | PubMed |
| 35184376 | The central role of Sphingosine kinase 1 in the development of neuroendocrine prostate cancer (NEPC): A new targeted therapy of NEPC. | Clin Transl Med | 2022 | https://conductscience.org/library/papers/35184376 | PubMed |
| 35177031 | Loss of REST in breast cancer promotes tumor progression through estrogen sensitization, MMP24 and CEMIP overexpression. | BMC Cancer | 2022 | https://conductscience.org/library/papers/35177031 | PubMed |
Genes10
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BDNF | 627 | PubTator's text mining | https://conductscience.org/library/genes/627 | NCBI Gene |
| CHGA | 1113 | PubTator's text mining | https://conductscience.org/library/genes/1113 | NCBI Gene |
| EGF | 1950 | PubTator's text mining | https://conductscience.org/library/genes/1950 | NCBI Gene |
| ERBB2 | 2064 | PubTator's text mining | https://conductscience.org/library/genes/2064 | NCBI Gene |
| EREG | 2069 | PubTator's text mining | https://conductscience.org/library/genes/2069 | NCBI Gene |
| ESR1 | 2099 | PubTator's text mining | https://conductscience.org/library/genes/2099 | NCBI Gene |
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
| PGR | 5241 | PubTator's text mining | https://conductscience.org/library/genes/5241 | NCBI Gene |
| POTEF | 728378 | PubTator's text mining | https://conductscience.org/library/genes/728378 | NCBI Gene |
| REST | 5978 | PubTator's text mining | https://conductscience.org/library/genes/5978 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20548947
GET https://conductscience.org/api/papers/v1/20548947/references?page=2